Header Logo

Connection

Sara Vesely to Leukemia, Lymphocytic, Chronic, B-Cell

This is a "connection" page, showing publications Sara Vesely has written about Leukemia, Lymphocytic, Chronic, B-Cell.
  1. Idelalisib activates AKT via increased recruitment of PI3Kd/PI3Kß to BCR signalosome while reducing PDK1 in post-therapy CLL cells. Leukemia. 2022 07; 36(7):1806-1817.
    View in: PubMed
    Score: 0.195
  2. SIRT3 overexpression and epigenetic silencing of catalase regulate ROS accumulation in CLL cells activating AXL signaling axis. Blood Cancer J. 2021 05 17; 11(5):93.
    View in: PubMed
    Score: 0.182
  3. Dynamics of microvesicle generation in B-cell chronic lymphocytic leukemia: implication in disease progression. Leukemia. 2017 02; 31(2):350-360.
    View in: PubMed
    Score: 0.131
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.